Apellis Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
APLS
CUSIP
03753U106
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 275 126 M $2.77 B
2024 Q4 290 127 M $4.05 B
2024 Q3 298 121 M $3.49 B
2024 Q2 292 121 M $4.64 B
2024 Q1 339 119 M $6.97 B
2023 Q4 336 120 M $7.17 B
2023 Q3 315 114 M $4.34 B
2023 Q2 373 108 M $9.81 B
2023 Q1 316 111 M $7.35 B
2022 Q4 278 105 M $5.44 B
2022 Q3 284 97.9 M $6.68 B
2022 Q2 235 91.7 M $4.15 B
2022 Q1 242 91.0 M $4.63 B
2021 Q4 208 82.7 M $3.91 B
2021 Q3 223 69.5 M $2.29 B
2021 Q2 235 65.3 M $4.13 B
2021 Q1 187 65.0 M $2.80 B
2020 Q4 182 63.9 M $3.65 B
2020 Q3 161 62.1 M $1.87 B
2020 Q2 158 61.4 M $2.00 B
2020 Q1 165 57.3 M $1.54 B
2019 Q4 162 44.6 M $1.37 B
2019 Q3 137 40.5 M $976 M
2019 Q2 103 40.5 M $1.03 B
2019 Q1 97 40.1 M $783 M
2018 Q4 97 32.5 M $429 M
2018 Q3 83 29.9 M $532 M
2018 Q2 75 29.7 M $654 M
2018 Q1 49 17.1 M $376 M
2017 Q4 46 15.7 M $340 M